Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Japan’s Asahi Glass has agreed to acquire CMC Biologics, a contract manufacturer of biologic drugs, for $510 million. The purchase continues the glass and chemical maker’s push into biologic drug manufacturing. In August, Asahi announced plans to buy the German contract manufacturer Biomeva. Private equity-owned CMC operates plants in Copenhagen, Seattle, and Berkeley, Calif., that produce biologic drug ingredients in mammalian and microbial hosts. It has about 530 employees.
This article has been sent to the following recipient: